Camber Pharmaceuticals launches generic Duexis
Camber Pharmaceuticals announces the addition of ibuprofen and famotidine Tablets to its current portfolio.
Supplier News
Upsher-Smith expands vigadrone franchise
MAPLE GROVE , Minn. – Upsher-Smith announced Tuesday the recent launch of vigadrone (vigabatrin) tablets, USP 500 mg, a fully substitutable, AB-rated generic version of Sabril (vigabatrin) Tablets, 500 mg. The company also offers vigadrone (vigabatrin) for Oral Solution, USP 500 mg.
Bausch + Lomb: Meeting all eye care needs
Dry eyes, contact lens dryness, self- and pet-care and rising health consciousness among the general population continue to be key drivers of the eye care product market. John Ferris, executive vice president, Consumer, Bausch + Lomb, highlights eye care trends in 2023.
Aurobindo gets FDA approval for saxagliptin tablets
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application saxagliptin tablets, 2.5mg and 5mg.
Chain Drug Review, Drug Store News and The Emerson Group join forces to honor NACDS’ 90th anniversary
In an unprecedented partnership, Chain Drug Review, Drug Store News, The Emerson Group and MMR are joining forces to celebrate the contributions of the National Association of Chain Drug Stores and community pharmacy retailers, as NACDS celebrates its 90th anniversary.
Camber launches generic Daptomycin for injection and generic Cubicin
PISCATAWAY, N.J. – Camber Pharmaceuticals is pleased to announce the addition of daptomycin for injection in both 350 mg and 500 mg strengths to its current portfolio.
RedSail Technologies announces integration between Axys and DosePlanner
RedSail Technologies, LLC, developer of Axys, is pleased to announce its integration with DosePlanner, a cloud-based medication management solution.
L’Oréal to keynote at CES 2024
L’Oréal CEO Nicolas Hieronimus will deliver the first-ever keynote from a beauty company at CES 2024, the tech event announced on Wednesday.
Genexa launches organic cherry flavor of kids’ pain & fever medicine
ATLANTA, Ga. – As parents stock up the medicine cabinet for back-to-school season, Genexa has introduced its best-selling children’s product in a new organic flavor – Kids’ Pain & Fever Cherry.
Upsher-Smith launches isotretinoin capsules
MAPLE GROVE, Minn. – Upsher-Smith announced the recent launch of isotretinoin capsules, USP in 10 mg, 20 mg, 30 mg, and 40 mg strengths.
Nirvana Water Sciences secures $2.625 million investment
Nirvana Water Sciences Corp. announced a further investment of $2.625 million by Flagstaff International, Inc. and other current investors.
Sanofi Consumer Healthcare North America earns B Corp Certification
After making strides in environmental sustainability and social impact commitments, Sanofi Consumer Healthcare North America announced it has earned B Corp Certification.
Camber launches generic Noxafi
PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of posaconazole delayed-release tablets to its current portfolio.
Bill introduced to include dietary supplements in FSA/HSA accounts
organizations representing dietary supplement manufacturers, marketers, and ingredient suppliers—applaud the introduction of the Dietary Supplements Access Act. This bipartisan legislation, introduced today by U.S.
Retailers uncork big sales with private label wine
Raise a glass to private label wine: dollar sales in all U.S. outlets jumped 9.1% to $52.2 million for the 52 weeks ending June 18, 2023, versus the same period the prior year, according to data from Circana. What’s more, unit sales grew 8% for the same period. Store brand spirits are